Ending TB in South-East Asia : flagship priority and response transformation
© 2023 Published by Elsevier Ltd..
Over the decades, the global tuberculosis (TB) response has evolved from sanatoria-based treatment to DOTS (Directly Observed Therapy Shortcourse) strategy and the more recent End TB Strategy. The WHO South-East Asia Region, which accounted for 45% of new TB patients and 50% of deaths globally in 2021, is pivotal to the global fight against TB. "Accelerate Efforts to End TB" by 2030 was adopted as a South-East Asia Regional Flagship Priority (RFP) in 2017. This article illustrates intensified and transformed approaches to address the disease burden following the adoption of RFP and new challenges that emerged during the COVID-19 pandemic. TB case notifications improved by 25% and treatment success rates improved by 6% between 2016 and 2019 due to interventions ranging from galvanising political commitments to empowering and engaging communities. Cumulative TB programme budget allocations in 2022 reached US$ 1.4 billion, about two and a half times the budget in 2016. An ambitious Regional Strategic Plan towards ending TB, 2021-2025, identifies priority interventions that will need investments of up to US$ 3 billion a year to fully implement them. Moving forward, countries in the Region need to leverage RFP and take up intensified, people-centred, holistic interventions for prevention, diagnosis, treatment and care of TB with commensurate investments and cross-ministerial and multi-sectoral coordination.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
The Lancet regional health. Southeast Asia - 18(2023) vom: 14. Nov., Seite 100301 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bhatia, Vineet [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 14.02.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.lansea.2023.100301 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365193119 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365193119 | ||
| 003 | DE-627 | ||
| 005 | 20240214232946.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.lansea.2023.100301 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1293.xml |
| 035 | |a (DE-627)NLM365193119 | ||
| 035 | |a (NLM)38028166 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bhatia, Vineet |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Ending TB in South-East Asia |b flagship priority and response transformation |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 14.02.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 Published by Elsevier Ltd. | ||
| 520 | |a Over the decades, the global tuberculosis (TB) response has evolved from sanatoria-based treatment to DOTS (Directly Observed Therapy Shortcourse) strategy and the more recent End TB Strategy. The WHO South-East Asia Region, which accounted for 45% of new TB patients and 50% of deaths globally in 2021, is pivotal to the global fight against TB. "Accelerate Efforts to End TB" by 2030 was adopted as a South-East Asia Regional Flagship Priority (RFP) in 2017. This article illustrates intensified and transformed approaches to address the disease burden following the adoption of RFP and new challenges that emerged during the COVID-19 pandemic. TB case notifications improved by 25% and treatment success rates improved by 6% between 2016 and 2019 due to interventions ranging from galvanising political commitments to empowering and engaging communities. Cumulative TB programme budget allocations in 2022 reached US$ 1.4 billion, about two and a half times the budget in 2016. An ambitious Regional Strategic Plan towards ending TB, 2021-2025, identifies priority interventions that will need investments of up to US$ 3 billion a year to fully implement them. Moving forward, countries in the Region need to leverage RFP and take up intensified, people-centred, holistic interventions for prevention, diagnosis, treatment and care of TB with commensurate investments and cross-ministerial and multi-sectoral coordination | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Flagship | |
| 650 | 4 | |a South-East Asia | |
| 650 | 4 | |a Tuberculosis | |
| 700 | 1 | |a Rijal, Suman |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Mukta |e verfasserin |4 aut | |
| 700 | 1 | |a Islam, Akramul |e verfasserin |4 aut | |
| 700 | 1 | |a Vassall, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Bhargava, Anurag |e verfasserin |4 aut | |
| 700 | 1 | |a Thida, Aye |e verfasserin |4 aut | |
| 700 | 1 | |a Basri, Carmelia |e verfasserin |4 aut | |
| 700 | 1 | |a Onozaki, Ikushi |e verfasserin |4 aut | |
| 700 | 1 | |a Pai, Madhukar |e verfasserin |4 aut | |
| 700 | 1 | |a Rezwan, Md Kamar |e verfasserin |4 aut | |
| 700 | 1 | |a Arinaminpathy, Nim |e verfasserin |4 aut | |
| 700 | 1 | |a Chandrashekhar, Padmapriyadarsini |e verfasserin |4 aut | |
| 700 | 1 | |a Sarin, Rohit |e verfasserin |4 aut | |
| 700 | 1 | |a Mandal, Sandip |e verfasserin |4 aut | |
| 700 | 1 | |a Raviglione, Mario |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet regional health. Southeast Asia |d 2022 |g 18(2023) vom: 14. Nov., Seite 100301 |w (DE-627)NLM342899503 |x 2772-3682 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2023 |g day:14 |g month:11 |g pages:100301 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.lansea.2023.100301 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2023 |b 14 |c 11 |h 100301 | ||